Dec - Closes additional Seed round led by Two Bear Capital

Sep - NIH Phase 1 grant to develop Alzheimer’s (tauopathies) therapy

Jul - Closes initial Seed round led by Two Bear Capital

Aug - Dr. Stiles named to NIH small business panel for aging & neurologic disorders

Jul - Dr. Stiles named to NIH/NINDS Special Emphasis Panel

Apr - NIH Phase 1B grant to develop MS therapy

May - NIH Phase 1B grant to develop SCI therapy

Feb - Dr. Stiles appointed Chair, RR&D Merit Review Board for Dept. of Veterans Affairs

Oct - J&J names Dr. Stiles to Under 40 to Watch List: 6 Young Trailblazing Scientists

Jun - Dr. Stiles featured speaker at Neurotech 2017

Sep - Dr. Stiles named 2016 Life Science Catalyst

Sep - 3rd Place at RESI Innovation Challenge

May - Named San Diego Life Science Startups to Watch in 2016 by Xconomy

Mar - U.S. patent granted for initial IP

Sep - NIH Phase 1 grant to develop MS therapy & supplemental award for stroke

Jul - Named 2015 Cool Company by San Diego Venture Group

Apr - NIH supplemental award for SCI therapy

Dec - Founders graduate from NIH’s inaugural I-Corp program

Jun - NIH Phase 1 grants to develop SCI and stroke therapies

Feb - Novoron founded